Collision tumour of the pleura composed of small cell carcinoma and malignant mesothelioma.
A H S
AH
Lee
I N
IN
Soomro
D000368:Aged; D000369:Aged, 80 and over; D001194:Asbestos / Q000506:poisoning; D015415:Biomarkers; D014408:Biomarkers, Tumor / Q000032:analysis; D019002:CD56 Antigen / Q000032:analysis; D064032:Calbindin 2; D002272:Carcinoembryonic Antigen / Q000032:analysis; D018288:Carcinoma, Small Cell / Q000209:etiology / Q000378:metabolism / Q000473:pathology*; D017809:Fatal Outcome; D006651:Histocytochemistry; D006801:Humans; D053555:Keratin-5; D007633:Keratins / Q000032:analysis; D008175:Lung Neoplasms / Q000209:etiology / Q000378:metabolism / Q000473:pathology*; D008297:Male; D008654:Mesothelioma / Q000209:etiology / Q000378:metabolism / Q000473:pathology*; D009378:Neoplasms, Multiple Primary / Q000209:etiology / Q000378:metabolism / Q000473:pathology*; D009687:Nuclear Proteins / Q000032:analysis; D016273:Occupational Exposure / Q000009:adverse effects; D010997:Pleural Neoplasms / Q000209:etiology / Q000378:metabolism / Q000473:pathology*; D064030:S100 Calcium Binding Protein G / Q000032:analysis; D000074482:Thyroid Nuclear Factor 1; D014157:Transcription Factors / Q000032:analysis; D014746:Vimentin / Q000032:analysis; D000951:Antigens, Neoplasm
D001194:Asbestos; D015415:Biomarkers; D014408:Biomarkers, Tumor; D019002:CD56 Antigen; D064032:Calbindin 2; D002272:Carcinoembryonic Antigen; D053555:Keratin-5; D007633:Keratins; D009687:Nuclear Proteins; D064030:S100 Calcium Binding Protein G; D000074482:Thyroid Nuclear Factor 1; D014157:Transcription Factors; D014746:Vimentin; C400901:CAM 5.2 antigen; C432845:HBME-1 antigen; D000951:Antigens, Neoplasm; C503940:KRT5 protein, human